Healthcare Realty Trust Stock
Price
Target price
-
-
-
-
-
?15.83
WKN: 886627 / Symbol: HR / Name: Healthcare Real / Stock / Residential & Commercial REIT / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Healthcare Realty Trust Stock
Our community is currently high on Healthcare Realty Trust with 3 Buy predictions and 0 Sell predictions.
However, we have a potential of -35.9% for Healthcare Realty Trust as the target price of 15 € is below the current price of 23.4 €.
Pros and Cons of Healthcare Realty Trust in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Healthcare Realty Trust vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Healthcare Realty Trust | - | - | - | - | - | - | - |
| Apollo Commercial Real Est. | -0.440% | 1.265% | -4.258% | 18.543% | -8.630% | -19.315% | -39.620% |
| Xenia Hotels & Resorts Inc | -0.750% | 2.290% | -2.899% | 15.517% | 8.943% | -12.418% | -29.025% |
| American Capital Agency | 1.050% | 0.962% | -5.240% | -3.107% | -4.968% | -40.408% | -46.193% |
Comments
Healthcare Realty Trust Incorporated (NYSE: HR) had its price target lowered by analysts at JPMorgan Chase & Co. from $19.00 to $17.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HR provided by MarketBeat
Healthcare Realty Trust Incorporated (NYSE: HR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Show more
Ratings data for HR provided by MarketBeat
Healthcare Realty Trust Incorporated (NYSE: HR) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $17.00 price target on the stock.
Show more
Ratings data for HR provided by MarketBeat
